Development of an HIV vaccine using a vesicular stomatitis virus vector expressing designer HIV-1 envelope glycoproteins to enhance humoral responses
Abstract Vesicular stomatitis virus (VSV), like many other Rhabdoviruses, have become the focus of intense research over the past couple of decades based on their suitability as vaccine vectors, transient gene delivery systems, and as oncolytic viruses for cancer therapy. VSV as a vaccine vector pla...
Gardado en:
| Principais autores: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BMC
2017-09-01
|
| Series: | AIDS Research and Therapy |
| Assuntos: | |
| Acceso en liña: | http://link.springer.com/article/10.1186/s12981-017-0179-2 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|